Zoetis Inc header image

Zoetis Inc

ZTS

Equity

ISIN null / Valor 19276994

New York Stock Exchange, Inc (2026-08-07)
USD 72.66-5.97%

Zoetis Inc
UMushroom community rating:

star star star star star
3.57 5 votes No rating yet
NegativeNeutralPositive

About company

Zoetis Inc. is a global leader in the animal health industry, providing a comprehensive range of products and services that cater to the health needs of animals. With operations spanning over 100 countries, the company's portfolio encompasses a wide array of medicines, vaccines, diagnostics, and technologies designed to support the health and well-being of animals across various sectors, including livestock and companion animals. Zoetis is recognized for its innovative approach in developing solutions that address both common and emerging health challenges faced by animals, thereby contributing significantly to the global animal health sector. The company's commitment to research and development is evident in its robust pipeline, which ensures a continuous introduction of new and improved products to the market, further solidifying its position as a key player in the animal health industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-51.0%1Y
-59.8%3Y
-64.0%5Y

Performance

38.4%1Y
30.8%3Y
29.6%5Y

Volatility

Market cap

30025 M

Market cap (USD)

Daily traded volume (Shares)

12,784,553

Daily traded volume (Shares)

1 day high/low

163.89 / 161.59

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.57

5 votes
Performance:
starstarstarstarstar
3.71
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Noah Juganar
UK, 23 Oct 2025
star star star star star
Solid fundamentals in financials & competitive advantages
D X
Switzerland, 16 Apr 2025
star star star star star
Langfristige Chance
D X
Switzerland, 29 Mar 2025
star star star star star
Ein Unternehmen, das meiner Meinung nach in einem zukunftsträchtigen Markt vorne mit dabei ist.

EQUITIES OF THE SAME SECTOR

Interparfums
Interparfums Interparfums Valor: 86977
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.48%EUR 24.82
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
10.03%USD 3.95
TransMedics Group Inc
TransMedics Group Inc TransMedics Group Inc Valor: 47361695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.59%USD 83.89
Krystal Biotech Inc
Krystal Biotech Inc Krystal Biotech Inc Valor: 38026052
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.17%USD 326.45
Ste Virbac SA
Ste Virbac SA Ste Virbac SA Valor: 524407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.44%EUR 345.00
FibroGen Inc
FibroGen Inc FibroGen Inc Valor: 25953994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.15%USD 7.27
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.64%CHF 125.98
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.68%CHF 102.90
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%CHF 73.65
Ramsay Generale de Sante SA
Ramsay Generale de Sante SA Ramsay Generale de Sante SA Valor: 1247709
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 10.90